Archives
Study: Negative D-dimer safely rules out DVT as a stand-alone test
16 Oct, 2020 | 09:26h | UTCNegative D-dimer safely ruled out DVT as a stand-alone test – Blood Advances
Randomized trial: Effect of sustained smoking cessation counseling and free medication vs. shorter-term counseling and medication advice on smoking abstinence
16 Oct, 2020 | 09:23h | UTCCommentary: Long-term, frequent phone counseling helps cancer patients who smoke quit – eCancer
Review: Evaluation and treatment of patients with hypercortisolism
16 Oct, 2020 | 09:24h | UTCEvaluation and Treatment of Patients With Hypercortisolism: A Review – JAMA Surgery
IDSA Position Statement: “Herd immunity” is not an answer to a pandemic
15 Oct, 2020 | 09:31h | UTC“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America
Commentary on Twitter
https://t.co/k15V8bMjiK via @IDSAInfo Excellent statement from @IDSAInfo & @HIVMA Presidents of why "herd immunity" is not an answer to a pandemic. These is the professional association representing > 12K specialists in infectious diseases so these are the real experts!
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Updated Cochrane Review shows electronic cigarettes can help people quit smoking
16 Oct, 2020 | 09:21h | UTCUpdated Cochrane Review shows electronic cigarettes can help people quit smoking – Cochrane Library
Original study: Electronic cigarettes for smoking cessation – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1316475634445672448
Perspective: Will SARS-CoV-2 become endemic?
15 Oct, 2020 | 09:29h | UTCWill SARS-CoV-2 become endemic? – Science
Commentary on Twitter
Whether #SARSCoV2 reinfections will be commonplace and how often they will occur remain to be understood, say authors in this Perspective. They also discuss what factors could drive the resultant pattern of endemicity if reinfection does become common. https://t.co/POKQ2byTYB pic.twitter.com/FMNbB8QR6p
— Science Magazine (@ScienceMagazine) October 14, 2020
Living with the COVID-19 pandemic: Act now with the tools we have
15 Oct, 2020 | 09:22h | UTCLiving with the COVID-19 pandemic: act now with the tools we have – The Lancet
Commentary on Twitter
NEW—Living with the #COVID19 pandemic: act now with the tools we have
J Bedford et al, @WHO STAG-IH, share a checklist for an epidemiologically based public health response to COVID-19, which is "neglected or inappropriately understood in some countries" https://t.co/vhjY0MsekB pic.twitter.com/Vb3B8OJNjr
— The Lancet (@TheLancet) October 9, 2020
Review: The duration of infectiousness of individuals infected with SARS-CoV-2
15 Oct, 2020 | 09:26h | UTCThe duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection
Commentary on Twitter
🔥NEW Review🔥#COVID19 pts with mild-to-moderate illness are highly unlikely to be infectious beyond 10 ds from symptom onset , However, limited studies found that Immunocompromised and severe-to-critical patients may be infectious for >10 days https://t.co/hogXvFpPEb pic.twitter.com/fBm5Se4RBf
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 13, 2020
Pediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: An overview
15 Oct, 2020 | 09:21h | UTC
Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts
15 Oct, 2020 | 09:17h | UTC
The 4 simple reasons Germany is managing Covid-19 better than its neighbors
15 Oct, 2020 | 09:19h | UTCThe 4 simple reasons Germany is managing Covid-19 better than its neighbors – Vox
See also: The German coronavirus mystery – UnHerd
WHO Global tuberculosis report 2020
15 Oct, 2020 | 09:35h | UTCGlobal tuberculosis report 2020 – World Health Organization
News release: WHO: Global TB progress at risk – World Health Organization
Executive summary: Global tuberculosis report 2020
Commentary: WHO warns of COVID impact on TB services – CIDRAP
Commentary on Twitter
The 🌏🌍🌏 has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop in deaths between 2015 and 2019.
🚨 #COVID19 will lead to setbacks if no action is taken urgently, according to 🆕 WHO report 👉https://t.co/5BvbGjaudU pic.twitter.com/A4edYfyOBH
— World Health Organization (WHO) (@WHO) October 14, 2020
Cluster randomized trial: Incentive programs for smoking cessation
15 Oct, 2020 | 09:09h | UTC
Commentary on Twitter
NEW paper @bmj_latest: #RCT of multiple incentive types for #smoking cessation in worksites in Thailand (SMILE trial). Large individual bonus most effective. https://t.co/CNdvhOo7Sb
With @WilliamHDow @c_lowenstein @UCBerkeleySPH and Aree Jampklay, Nucharee Srivirojana @MahidolU pic.twitter.com/q9B61wyzrf
— Justin White (@justinswhite) October 14, 2020
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society–USA Panel
15 Oct, 2020 | 09:13h | UTC
Commentary on Twitter
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults https://t.co/J3zHm9rpkY via @JAMA_current The new @IAS_USA ART guidelines document is out. Enormous effort led by @msaagmd with @RMKGandhi @doc_in_a_box @drmt @PaulSaxMD @joseph_eron and others on panel.
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Phase 3 trials show positive results for cefiderocol, but questions remain
15 Oct, 2020 | 09:07h | UTCPhase 3 trials show positive results for cefiderocol, but questions remain – CIDRAP
Five things clinicians and patients should question in public health
15 Oct, 2020 | 09:05h | UTCFive Things Clinicians and Patients Should Question – Choosing Wisely Canada
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Podcast: Ten things every new doctor should know about drug reactions
15 Oct, 2020 | 09:02h | UTCTen Things Every New Doctor Should Know About Drug Reactions – JAMA
Study: Real-world blood pressure measurements vs. measurements taken in the SPRINT trial
15 Oct, 2020 | 09:00h | UTCCommentaries: A Tale of 2 Blood Pressures – JAMA Internal Medicine AND Real-World BP Measurements vs SPRINT Protocol – Physician’s Weekly
Commentary on Twitter
Incredibly important paper in @JAMAInternalMed demonstrating poor concordance between clinic blood pressure and trial based blood pressure. https://t.co/waLTYk9Lnu
— Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS (@spjuraschek) October 13, 2020
Richard Smith: Are all lives and deaths equal?
15 Oct, 2020 | 08:58h | UTCRichard Smith: Are all lives and deaths equal? – The BMJ Opinion
Study: Polypharmacy (taking > 10 medications) is common in older patients with heart failure
15 Oct, 2020 | 09:03h | UTCPolypharmacy in Older Adults Hospitalized for Heart Failure – Circulation: Heart Failure
Commentaries: Ten or more medications, often prescribed to older heart failure patients, raises concerns – American Heart Association AND Polypharmacy Common Among Older Heart Failure Patients – Physician’s Weekly
Commentary on Twitter
New work from @OzanUnluMD @ParagGoyalMD indicates that polypharmacy (taking > 10 medications) is common in older patients with #heartfailure, and is primarily due to non-cardiovascular meds #AHAJournals @WeillCornell | https://t.co/hL0GZLaCnT pic.twitter.com/BHppxDQgor
— Circ: Heart Failure (@CircHF) October 13, 2020
Genomic evidence for reinfection with SARS-CoV-2: A case study
14 Oct, 2020 | 09:39h | UTCGenomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases
Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME
Related: Dutch woman dies after catching Covid-19 twice, the first reported reinfection death – CNN
Perspective: Why does a high-impact publication matter so much for a career in research?
15 Oct, 2020 | 08:56h | UTCWhy does a high-impact publication matter so much for a career in research? – Nature
Updated NIH COVID-19 Treatment Guidelines
14 Oct, 2020 | 09:41h | UTCCoronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
See also: What’s New in the Guidelines
COVID-19 in New Zealand and the impact of the national response: A descriptive epidemiological study
14 Oct, 2020 | 09:38h | UTCCommentary: Lessons from New Zealand’s COVID-19 outbreak response – The Global Health
Commentary on Twitter
How New Zealand crushed covid: rapid, aggressive use of masks, distancing, testing, isolation, travel ban. Hard work.
Transmission chains notable (wedding, school clusters)https://t.co/FMCgQOsVYJhttps://t.co/svRZyjvOf2 @AlxsRobert @TheLancetPH 🇳🇿👏👏 pic.twitter.com/WqxAySjqJy— Eric Topol (@EricTopol) October 14, 2020
COVID-19 and cancer: Current challenges and perspectives
14 Oct, 2020 | 09:35h | UTCCOVID-19 and Cancer: Current Challenges and Perspectives – Cancer Cell